RT @Cochrane_IDG: New open access @Cochrane_IDG review published today: #Primaquine at alternative dosing schedules for preventing relapse…
Primaquine pour guérir les personnes atteintes de paludisme à Plasmodium vivax: comparaison des schémas posologiques https://t.co/hQ1upTOUMx
📢¡NUEVA REVISIÓN COCHRANE EN ESPAÑOL!💬📖 "Primaquina en esquemas de dosificación alternativos para la prevención de la recaída en pacientes con paludismo por Plasmodium vivax" Ya disponible en la Biblioteca Cochrane👇 https://t.co/HCkn8JwtiL
Primaquine to cure people with Plasmodium vivax #malaria : comparing dosing schedules https://t.co/IlHwFD1h71
RT @Cochrane_IDG: New open access @Cochrane_IDG review published today: #Primaquine at alternative dosing schedules for preventing relapse…
Does a shorter, higher, or monthly treatment course of primaquine prevent Plasmodium vivax #malaria relapses? Just published Cochrane review for evidence to date https://t.co/TXjPwg2dhf @Cochrane_IDG @jcu @AITropHealthMed @CPHMVS_JCU
RT @Cochrane_IDG: New open access @Cochrane_IDG review published today: #Primaquine at alternative dosing schedules for preventing relapse…
New open access @Cochrane_IDG review published today: #Primaquine at alternative dosing schedules for preventing relapse in people with #Plasmodium vivax malaria https://t.co/VPBrpRe0ch @epivec @PaulGarnerWoof #Cochrane #CochraneEvidence